Bert van Geel - Concepedia

Concepedia

Author

Bert van Geel

Rotterdam University of Applied Sciences

Also Known As

B van Geel, B. van Geel, Bert van Geel

10

Publications

1.3K

Citations

7

H-Index

22

Concepts

All Affiliations

Rotterdam University of Applied Sciences Erasmus MC Erasmus University Rotterdam

BV

About

Bert van Geel is an author at Rotterdam University of Applied Sciences specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	78
2	Orthopaedics	2	2	24
3	Health Sciences	1	1	13
4	Endocrinology	1	1	11
5	Obstetrics	1	1	11

Bert van Geel

×

7

Publications

1.3K

Citations

7

H-Index

	Year	Citations
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten, New England Journal of Medicine	2001	954
Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a <i>BRCA1</i> or <i>BRCA2</i> Mutation Hanne Meijers-Heijboer, Cecile T.M. Brekelmans, Marian B. E. Menke‐Pluymers, Journal of Clinical Oncology	2003	118
Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Mieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, Journal of Clinical Oncology	2009	103
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients Mieke Kriege, Caroline Seynaeve, Hanne Meijers‐Heijboer, Breast Cancer Research and Treatment Breast OncologyBreast Cancer PatientsMedicinePathologyBreast Cancer	2007	35
Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853) I S Fentiman, Jean‐Pierre Julien, J.A. van Dongen, European Journal of Cancer and Clinical Oncology Breast OncologyRandomised TrialClinical TrialsBreast ImagingBreast Cancer	1991	19
Isolated limb perfusion (ILP) with high dose TNF-α, gamma-IFN and melphalan in patients with irresectable soft tissue sarcomas: A highly effective limb saving procedure H. Schraffordt Koops, A.M.M. Eggermont, D Liénard, European Journal of Cancer Surgical OncologyLimb ReconstructionEffective LimbHigh Dose Tnf-αMedicine	1993	13
The relation between pharmacokinetics and endocrine effects of buserelin implants in patients with mastalgia Jan G. M. Klijn, Bert van Geel, Frank H. de Jong, Clinical Endocrinology Hormonal ContraceptiveUrologyBuserelin ImplantsEndocrine MechanismEndocrine Effects	1991	11

Page 1